Financial Feasibility of Developing Sustained-Release Incrementally Modified Drugs in Thailand’s Pharmaceutical Industry: Mixed Methods Study <div xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="section"> <a class="named-anchor" id="d3102995e277"> <!-- named anchor --> </a> ...

📄 'Financial Feasibility of Developing Sustained-Release Incrementally Modified Drugs in Thailand’s Pharmaceutical Industry: Mixed Methods Study' - a @jmirpub.bsky.social #JMIRx Med article on #ScienceOpen:

🖇️ #PharmaEconomics #R&D #DrugInnovation #IMD #ThailandPharma

Genitourinary Drugs Market Size, Industry Growth, Trends 2032 Genitourinary Drugs Market to reach USD 72.9 billion at CAGR 3.6% by 2032, Genitourinary Drugs Industry top company Analysis by Disease, Product, End User, sales, regions - forecast 2024-2032.

🧬🚻 Genitourinary health is in focus! Explore how new drugs are improving life for millions battling GU conditions.
#GenitourinaryCare #UrologyHealth #DrugInnovation #PharmaTrends #GlobalHealthcare #LifeSciences

www.marketresearchfuture.com/reports/geni...

Colorado revises laws on investigational drug availability and patient eligibility Colorado amends statutes to clarify investigational drug access for eligible patients

Colorado is paving the way for patients by amending laws to make investigational drugs more accessible!

Get the details!

#CO #DrugInnovation #CitizenPortal #HealthcareAccess #PatientRights

House Bill 25-1270 enables access to investigational drugs for eligible patients Eligible patients may request investigational drugs with parent or guardian consent.

A groundbreaking House Bill in Colorado now allows eligible patients to access investigational drugs with the support of their parents or guardians!

Click to read more!

#CO #DrugInnovation #CitizenPortal #HealthcareAccess #PatientRights

Healthcare Matters Podcast A podcast dedicated to bringing you a simplified rundown of not-so-simple matters in healthcare economic and policy issues.

New #HealthcareMatters 🎧
Leadership chaos. HHS layoffs. FDA instability. We talk with former FDA Associate Commissioner Peter Pitts about how policy turmoil threatens innovation and patient access.
Listen now → ghlf.org/healthcarema...
#FDA #HealthPolicy #DrugInnovation #PatientCare

Philanthropy can help create a healthier biotech ecosystem Small biotech companies are the heart of drug innovation, but they need help. Philanthropy is their best hope.

Oh no- some of my interest areas are colliding! @mixedkracker.bsky.social and I have a new piece out in STAT First Opinion about the role philanthropy should take on in drug innovation - read more here!

www.statnews.com/2025/03/24/b...

#druginnovation #philanthropy #socialjusticephilanthropy